TREATMENT IN METASTATIC PROSTATE CANCER WITH HORMONE REFRACTORY

被引：0
|
作者：
Vitello, S. [2 ]
Vacirca, F. [1 ]
Triglia, E. [2 ]
Giarratano, G. [2 ]
机构：
[1] Osp S Elia, UO Urol, Caltanissetta, Italy
[2] Osp S Elia, UO Oncol Med, Caltanissetta, Italy
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 14期
关键词：
D O I：
10.1016/j.ejcsup.2008.06.054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] Ifosfamide (IFO) in the treatment of metastatic hormone refractory prostate cancer
    KellokumpuLehtinen, P
    Lehtinen, T
    Tammela, T
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 128 - 128
  • [2] Docetaxel re-treatment for metastatic hormone refractory prostate cancer
    Ansari, J.
    Hussain, S. A.
    Zarkar, A.
    Bliss, J.
    Tanguay, J. S.
    Glaholm, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] HORMONE REFRACTORY METASTATIC PROSTATE-CANCER
    STERNBERG, CN
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 331 - 335
  • [4] State-of-the-art treatment of metastatic hormone-refractory prostate cancer
    Goodin, S
    Rao, KV
    DiPaola, RS
    ONCOLOGIST, 2002, 7 (04): : 360 - 370
  • [5] DocetaxelIn Hormone-Refractory Metastatic Prostate Cancer
    Kate McKeage
    Susan J. Keam
    Drugs, 2005, 65 : 2287 - 2294
  • [6] Docetaxel in hormone-refractory metastatic prostate cancer
    Oh, WK
    DRUGS, 2005, 65 (16) : 2296 - 2297
  • [7] Intermittent chemotherapy for metastatic hormone refractory prostate cancer
    Lin, Amy M.
    Ryan, Charles J.
    Small, Eric J.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 243 - 254
  • [8] Current place of chemotherapy in the treatment of hormone-refractory metastatic prostate cancer.
    Breton, X
    Lechevallier, E
    Coulange, C
    PROGRES EN UROLOGIE, 2005, 15 (03): : 398 - 404
  • [9] The role of doxorubicin and epirubicin for the treatment of patients with metastatic hormone-refractory prostate cancer
    Petrioli, Roberto
    Pascucci, Alessandra
    Francini, Edoardo
    Fiaschi, Anna Ida
    Sciandivasci, Angela
    Miano, Salvatora
    Marsili, Stefania
    Francini, Guido
    ANNALS OF ONCOLOGY, 2007, 18 : 74 - 74
  • [10] The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
    Petrioli, Roberto
    Fiaschi, Anna Ida
    Francini, Edoardo
    Pascucci, Alessandra
    Francini, Guido
    CANCER TREATMENT REVIEWS, 2008, 34 (08) : 710 - 718
12345